SCN2A channelopathies: Mechanisms and models.

Area of Science:

• Neurogenetics
• Molecular Neuroscience
• Channelopathies

Background:

• The SCN2A gene encodes the voltage-gated sodium channel Na_V1.2, crucial for neuronal function.
• SCN2A variants are associated with a spectrum of severe neurodevelopmental and epileptic disorders.
• These disorders range from mild intellectual disability to severe developmental and epileptic encephalopathy.

Purpose of the Study:

• To summarize functional mechanisms of SCN2A channelopathies.
• To correlate genotypes with observed clinical phenotypes.
• To review available models for understanding SCN2A-related disorders and potential treatments.

Main Methods:

• Review of functional analyses of SCN2A channel defects.
• Correlation of genetic variants with clinical presentations (genotype-phenotype correlation).
• Analysis of existing disease models for SCN2A channelopathies.

Main Results:

• SCN2A variants lead to diverse neurological phenotypes, including epilepsy and intellectual disability.
• Functional studies reveal genotype-phenotype correlations, guiding treatment strategies.
• Gain-of-function variants in SCN2A suggest specific therapeutic avenues.

Conclusions:

• SCN2A channelopathies represent a significant cause of early-onset neurological and developmental disorders.
• Understanding the functional impact of SCN2A variants is key to developing targeted therapies.
• Available models aid in deciphering the complex mechanisms underlying SCN2A-related diseases.